Pediatric Hematology and Oncology

Papers
(The median citation count of Pediatric Hematology and Oncology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Ruxolitinib for steroid-refractory graft versus host disease in pediatric HSCT: high response rate and manageable toxicity21
COVID-19 outcomes in a large pediatric hematology-oncology center in Houston, Texas18
Efficacy and safety of immunosuppressive therapy with or without eltrombopag in pediatric patients with acquired aplastic anemia: A Chinese retrospective study16
COVID19 in children with cancer in low- and middle-income countries: Experience from a cancer center in Chennai, India13
Efficacy and safety of eltrombopag in the first-line therapy of severe aplastic anemia in children13
Primary prevention of stroke in children with sickle cell anemia in sub-Saharan Africa: rationale and design of phase III randomized clinical trial13
Azacitidine and prophylactic donor lymphocyte infusions after hematopoietic stem cell transplantation for pediatric high-risk acute myeloid leukemia11
Vascular endothelial growth factor response with propranolol therapy in patients with infantile hemangioma10
Electrostatic Complementarity of T-Cell Receptor-Alpha CDR3 Domains and Mutant Amino Acids Is Associated with Better Survival Rates for Sarcomas10
COVID-19 reinfection in two children with cancer9
Clinical variability in multifocal lymphangioendotheliomatosis with thrombocytopenia: a review of the literature8
Intravenous anakinra for tisagenlecleucel-related toxicities in children and young adults7
Association of body mass index with toxicity and survival in pediatric patients treated with cisplatin-containing regimens7
Outcomes of blinatumomab based therapy in children with relapsed, persistent, or refractory acute lymphoblastic leukemia: a multicenter study focusing on predictors of response and post-treatment immu7
Efficacy and safety of vemurafenib in Langerhans cell histiocytosis (LCH): A systematic review and meta-analysis7
The clinicopathological profile and value of multidisciplinary management of pediatric brain tumors in a low-income setting7
Current status of African pediatric oncology education efforts aligned with the Global Initiative for Childhood Cancer7
Outcome and prognostic factors in childhood B non-Hodgkin lymphoma from India: Report by the Indian Pediatric Oncology Group (InPOG-NHL-16-01 study)6
IL-10 and TNFα are associated with decreased survival in low-risk pediatric acute myeloid leukemia; a children’s oncology group report6
Weight status and health behaviors of adolescents and young adults with sickle cell disease: The emerging risk for obesity6
Survival in patients with high-risk neuroblastoma treated without autologous stem cell transplant or dinutuximab beta6
Breakthrough bleeding episodes in pediatric severe hemophilia a patients with and without inhibitors receiving emicizumab prophylaxis: a single-center retrospective review6
Arsenic trioxide in pediatric cancer – a case series and review of literature6
ABCC4, ITPA, NUDT15, TPMT and their interaction as genetic predictors of 6-mercaptopurine intolerance in chinese patients with acute lymphoblastic leukemia6
Secondary hemophagocytic lymphohystiocytosis in a Rubinstein Taybi syndrome patient6
Immune thrombocytopenia following multisystem inflammatory syndrome in children (MIS-C) – a case series6
Traumatic lumbar punctures in diagnostic and intrathecal treatment punctures of pediatric hemato-oncology patients6
The effects of NUDT15 and TPMT variants on mercaptopurine treatment in Vietnamese pediatric acute lymphoblastic leukemia patients5
The announcement of treatment resistance from the pediatric oncologist’s point of view: a qualitative study5
Outcomes of pediatric mixed phenotype acute leukemia treated with lymphoid directed therapy: Analysis of an institutional series from India5
Evaluating the baseline survival outcomes of the “six Global Initiative for Childhood Cancer index cancers” in Africa5
When to suspect GATA2 deficiency in pediatric patients: from complete blood count to diagnosis5
Clinical Characteristics and Outcomes of 101 Children with Hemophagocytic Lymphohistiocytosis: A Four-Year Single-Center Experience from Egypt5
Treatment of infantile fibrosarcoma associated to an abdominal aortic aneurysm with larotrectinib: a case report5
Heterozygous CTLA4 splice site mutation c.458-1G > C presenting with immunodeficiency and variable degree of immune dysregulation in three generation kindred of Caribbean descent5
High grade gliomas in young children: The South Thames Neuro-Oncology unit experience and recent advances in molecular biology and targeted therapies5
Superficial CD34-Positive Fibroblastic Tumor on the Chest Wall of an 8-Year-Old Girl: A Case Report and Literature Review5
Late effects care for childhood brain Tumor Survivors: A Quality-Improvement Initiative4
Glucocorticoid resistance induced by ANXA5 overexpression in B-cell acute lymphoblastic leukemia4
Clinical characteristics and outcomes of combined thrombolysis and anticoagulation for pediatric and young adult lower extremity and inferior vena cava thrombosis4
PASTEC - a prospective, single-center, randomized, cross-over trial of pure physical versus physical plus attentional training in children with cancer4
Prevalence of the BRAF V600E mutation in Greek adults with Langerhans cell histiocytosis4
MicroRNA-199a deficiency relates to higher bone marrow blasts, poor risk stratification and worse prognostication in pediatric acute myeloid leukemia patients4
Impact of the COVID-19 pandemic on health-related quality of life and anxiety in pediatric hematology/oncology patients4
Incidence and Risk Factors of Venous Thromboembolism in Childhood Acute Lymphoblastic Leukaemia – a Population-Based Analysis of the Austrian Berlin-Frankfurt-Münster (BFM) Study Group4
Study of the diagnostic criteria for hemophagocytic lymphohistiocytosis in neonatal and pediatric patients with severe sepsis or septic shock4
Seasonal variation of respiratory viral infections: a comparative study between children with cancer undergoing chemotherapy and children without cancer4
Changes in anthropometrical status and body composition in children with cancer during initial chemotherapy4
Impact of minimal residual disease on relapse in childhood acute lymphoblastic leukemia: Lessons learnt from a tertiary cancer center in India4
Accuracy of online medical information: the case of social media in sickle cell disease4
Familial hemophagocytic lymphohistiocytosis induced by SARS-CoV-24
Clinical characteristics and successful treatment outcomes of children and adolescents with Kaposi sarcoma in Southwestern Tanzania4
Combined immunodeficiency with marginal zone lymphoma due to a novel homozygous mutation inIL-21Rgene and successful treatment with hematopoietic stem cell transplantation4
Early mortality continues to be a barrier to excellent survival in childhood acute promyelocytic leukemia: a retrospective study of 62 patients spanning 17 years4
Global caregiver concerns of SARS-CoV-2 vaccination in children with cancer: a cross-sectional mixed-methods study3
Post-transplant CD34+ selected stem cell boost as an intervention for declining mixed chimerism following reduced intensity conditioning allogeneic stem cell transplant in children and young adults wi3
Nodular lymphocyte predominant Hodgkin lymphoma: Experience of Polish Pediatric Leukemia/Lymphoma Study Group3
Analysis of survival rates and prognosis of hepatoblastoma in children: a retrospective study from a single center in China3
Usefulness of functional splicing analysis to confirm precise disease pathogenesis in Diamond-Blackfan anemia caused by intronic variants in RPS193
Complete and durable response to immune checkpoint inhibitor in a patient with refractory and metastatic hepatoblastoma3
Hemophagocytic lymphohistiocytosis associated with parvovirus B19-induced aplastic crisis in a hereditary spherocytosis patient: A case report and literature review3
Safety and efficacy of deferasirox in patients with transfusion-dependent thalassemia: A 4-year single-center experience3
Retrospective single-center experience with OEPA/COPDAC and PET-CT based strategy for pediatric Hodgkin lymphoma in a LMIC setting3
Clinical practice guidelines on management of infantile hemangioma: a systematic quality appraisal using the AGREE II instrument3
Retrospective analysis of predisposing factors for difficult lumbar punctures requiring image guidance in pediatric oncology patients3
Clinical profile, outcome and challenges in the management of pediatric Burkitt lymphoma: a single center experience3
Outcome and complications of pediatric acute promyelocytic leukemia in Bangladesh3
TPMT polymorphisms and minimal residual disease after 6-mercaptopurine post-remission consolidation therapy of childhood acute lymphoblastic leukaemia3
A brief review of the current knowledge on environmental toxicants and risk of pediatric cancers3
KIF11 as a potential cancer prognostic marker promotes tumorigenesis in children with Wilms tumor3
Gross motor disorders in pediatric patients with acute lymphoblastic leukemia and survivors: A systematic review3
How to recognize inborn errors of immunity in a child presenting with a malignancy: guidelines for the pediatric hemato-oncologist3
Association between in-line filtration and Type I hypersensitivity reactions in pediatric oncology patients receiving intravenous etoposide3
Heart rate response and chronotropic incompetence during cardiopulmonary exercise testing in childhood acute lymphoblastic leukemia survivors3
Clinical Profile and Outcomes of Primary Immunodeficiency and Malignancy in Childhood at a Tertiary Oncology Center in Developing Country3
Fertility preservation education for pediatric hematology-oncology fellows, faculty and advanced practice providers: a pilot study3
Prevalence and Risk Factors for Pulmonary Embolism in Pediatric Sickle Cell Disease: A National Administrative Database Study3
Toward 2030: SIOP Africa adopts the Global Initiative for Childhood Cancer3
Hereditary red blood cell membrane defects. Detection of PIEZO1 mutations associated with SPTA1 mutations. An unusual clinical case of hereditary xerocytosis3
MiR-143-3p Inhibits Cell Proliferation in Pedatric Acute Myeloid Leukemia via Inhibition of KAT6A2
Novel Strategy Involving High-Dose Chemotherapy with Stem Cell Rescue Followed by Intrathecal Topotecan Maintenance Therapy without Whole-Brain Irradiation for Atypical Teratoid/Rhabdoid Tumors2
German physicians’ perceptions and views on complementary medicine in pediatric oncology: a qualitative study2
High dose methotrexate containing regimen in pediatric non-metastatic extremity osteosarcoma patients: experience from a tertiary cancer center in India2
The efficacy and safety of midazolam with fentanyl versus midazolam with ketamine for bedside invasive procedural sedation in pediatric oncology patients: A randomized, double-blinded, crossover trial2
The expression of PHOX2B in bone marrow and peripheral blood predicts adverse clinical outcome in non-high-risk neuroblastoma2
Chemotherapy supply chain management, safe-handling and disposal in Ethiopia: the case of Tikur Anbessa specialized hospital2
Vincristine-induced neurotoxicity in pediatric patients with rhabdomyosarcoma: A retrospective analysis of clinical features and outcome2
A chronic eyelid lesion in a child: multi-disciplinary approach to diagnosis, treatment and management of a highly atypical histiocytic lesion2
Early Decline of Neuron-Specific Enolase during Neuroblastoma Chemotherapy is a Predictive Factor of Clinical Outcome2
Symptomatic osteonecrosis in French survivors of childhood and adolescent leukemia: a clinical and MRI study of LEA cohort2
Methotrexate concentrations and associated variability factors in high dose therapy of children with acute lymphoblastic leukemia and non-Hodgkin lymphoma2
Epigenetic age acceleration among survivors of pediatric medulloblastoma and primitive neuroectodermal tumor2
Abdominal lymphadenopathy in children with Gaucher disease: Relation to disease severity and glucosylsphingosine2
Delayed diagnosis of Griscelli syndrome type 2 with compound heterozygote RAB27A variants presenting with pulmonary failure2
Expression of YY1 in pro-B and T phenotypes correlation with poor survival in pediatric acute lymphoblastic leukemia2
Intracerebral hemorrhage as a rare complication of imatinib in a Philadelphia chromosome positive acute lymphoblastic leukemia pediatric patient2
Microsatellite instability-high is rare events in refractory pediatric solid tumors2
Two patients of trisomy 21 with transient abnormal myelopoiesis with hypereosinophilia without blasts in peripheral blood smears2
Estimation of iron overload with T2*MRI in children treated for hematological malignancies2
Circulating tumor DNA sequencing of pediatric solid and brain tumor patients: An institutional feasibility study2
The time to diagnosis and survival in children with solid tumors and lymphoma: results from a single center in Turkey2
Molecular genetic testing enabled the diagnosis of otherwise undiagnosable cases of pyruvate kinase deficiency2
Delayed therapy initiation for a case with congenital leukemia with transient spontaneous regression2
Health-related quality of life among Malaysian pediatric survivors of central nervous system tumor2
Histiocytic sarcoma arising in a child affected by Burkitt lymphoma, with t(8;14)(q24;q32) positivity in both tumors2
Assessment of cystatin C in pediatric sickle cell disease and β-thalassemia as a marker of subclinical cardiovascular dysfunction: a case-control study2
The predictive utility of cytokines, procalcitonin and C-reactive protein among febrile pediatric hematology and oncology patients with severe sepsis or septic shock2
Complicated bleeding challenge and intraoperative safety strategies in a case of hemophilia a with rhabdomyosarcoma2
Application of microRNAs in the diagnosis and monitoring of pediatric germ cell tumors: Kazakh experience2
Bilateral adrenal primary tumor in Stage 4S neuroblastoma: The Italian experience and review of the literature2
Prognostic significance of survivin expression in pediatric ewing sarcoma2
Clinical review of COVID-19 in children and adolescents with cancer: Experience from a tertiary care center in East India2
Hemolymphangioma invasion of R scapula and mediastinum: a rare case report2
Transient abnormal myelopoiesis in Down syndrome: Experience of long term follow up from a single tertiary center in Thailand2
Comparison of outcomes of children with acute lymphoblastic leukemia treated with BMF protocol across 2 decades2
Assessment of depression in children and adolescents with sickle cell anemia in a low-resource setting: a comparative study2
Fecal microbiota of adolescent and young adult cancer survivors and metabolic syndrome: an exploratory study1
Safety of Procalcitonin Guided Early Discontinuation of Antibiotic Therapy among Children Receiving Cancer Chemotherapy and Having Low-Risk Febrile Neutropenia: A Randomized Feasibility Trial (ProFenC1
The significance of surveillance imaging in children with Ewing sarcoma and osteosarcoma1
Tyrosine kinase inhibitor treatment and long-term follow-up for metastatic malignant struma ovarii1
Rare inherited coagulation disorders in young children in Oman1
Noncompliance of pediatric cancer patients with chemotherapy: A single-center experience in a lower-middle income country1
Barriers to Accessing Fertility Preservation in Adolescents with Hodgkin Lymphoma in India1
Innate Immune Mechanism of Neutrophil Extracellular Trap Formation is Impaired in at-Risk Term Low Birth Weight Newborns1
The global challenge of treating disseminated LCH1
Low EVI1 expression at diagnosis predicted poor outcomes in pediatric Ph-negative B cell precursor acute lymphoblastic leukemia patients1
Intrauterine Growth Retardation is a Risk Factor for Anthracycline Toxicity1
Dual enzyme therapy improves adherence to chemotherapy in a patient with gaucher disease and Ewing sarcoma1
The combination of clofarabine, etoposide, and cyclophosphamide shows limited efficacy as a bridge to transplant for children with refractory acute leukemia: results of a monitored prospective study1
Intra-arterial chemotherapy for rhabdomyosarcoma1
Potential role of serum vitamin D as a risk factor in pediatric acute lymphoblastic leukemia1
Introducing isotonic fluids into pediatric oncology1
A single assessment of methotrexate levels at 42 hours permits safe administration and early discharge in children with lymphoblastic lymphoma and leukemia receiving high-dose methotrexate1
Outcome of pediatric germ cell tumor with comparison of carboplatin and cisplatin based regimens: A 10-year analysis1
Chlorhexidine gluconate (CHG) foam improves adherence, satisfaction, and maintains central line associated infection rates compared to CHG wipes in pediatric hematology-oncology and bone marrow transp1
Multicenter real-world experience of the clinical efficacy and tolerance of pazopanib in high-risk pediatric solid tumors (PazoPed)1
Acute myeloid leukemia in a child with familial platelet disorder and a cryptic runx1 intragenic deletion1
SACCSG HL-2018. Barriers and enablers of a harmonized treatment protocol for childhood and adolescent Hodgkin lymphoma in South Africa1
Therapeutic efficacy of RAS inhibitor trametinib using a juvenile myelomonocytic leukemia patient-derived xenograft model1
Near-Haploid B-Cell Acute Lymphoblastic Leukemia in a Patient with Rubinstein-Taybi Syndrome1
Hypothyroidism in children with Hb E/β-thalassemia compared between those who received regular transfusion and those who underwent hematopoietic stem cell transplantation1
Impact of restrictive measures due to the Covid-19 pandemic on the incidence of immune thrombocytopenia in children: an Italian single center experience1
Brachial plexus chloroma as a presenting feature of relapse in a child with KMT2A-rearranged acute lymphoblastic leukemia, a case report1
Treatment of Langerhans cell histiocytosis with subcutaneous cytarabine1
Osteosarcoma emboli presenting as chronic thromboembolic pulmonary hypertension in a child1
Whole genome sequencing and inheritance-based variant filtering as a tool for unraveling missing heritability in pediatric cancer1
Internal evaluation of risk stratification tool using serial procalcitonin and clinical risk factors in pediatric febrile neutropenia: The non-interventional, single institution experience prior to cl1
Real-world implementation of North American and SIOP strategies for the treatment of Wilms tumor in Uruguay1
Impact of socio-behavioral measures implemented during the SARS-CoV-2 pandemic on the outcomes of febrile neutropenia episodes in pediatric cancer patients: a single center quasi-experimental pre-post1
Allogeneic hematopoietic stem cell transplantation in an adolescent with Prader-Willi syndrome – unique considerations1
Therapeutic drug monitoring of intravenous busulfan in Thai children undergoing hematopoietic stem cell transplantation: A pilot study1
Thalassemia patients in transfussion dependent period and after hematopoietic stem cell transplantation: how are the psychiatric status and life quality of these patients?1
Acute liver failure in a four-year old girl during maintenance therapy of acute lymphoblastic leukemia1
How do you tell parents whose child has cancer that the treatment has failed: A qualitative study on pediatric oncologists’ practices1
Challenges in Management of Pediatric Chronic Myeloid Leukemia (pCML) in the Low-Middle Income Countries (LMICs): Insights from an International CML Foundation (iCMLf) Multi-National Survey1
Palifermin as primary mucositis prophylaxis in patients with B-cell Non-Hodgkin lymphoma: a case series1
Endoscopic findings and predictors of gastrointestinal lesions in children with iron deficiency anemia1
GATA2-related myeloid neoplasms in pediatrics: where do we stand?1
Physician risk perceptions and surveillance practices for tyrosine kinase inhibitor long-term effects in pediatric CML1
Presence of identical B-cell clone in both cerebrospinal fluid and tumor tissue in a patient with opsoclonus–myoclonus syndrome associated with neuroblastoma1
Contribution of Fatigue to Cognitive Dysfunction in Childhood Acute Lymphoblastic Leukemia Survivors1
Managing pediatric chronic myeloid leukemia in Africa: the Botswana experience with two cases1
Guillain-Barré syndrome after bortezomib therapy in a child with relapsed acute lymphoblastic leukemia1
Timely diagnostics and safe procedures in children with anterior mediastinal masses (AMMs): a qualitative review of the AMM protocol at BC Children’s Hospital in Vancouver BC1
Rhabdomyosarcoma as the first presentation in Neurofibromatosis Type 1: case series and review of the literature1
Clinical profile and outcome of children with anaplastic large cell lymphoma treated with short-course chemotherapy – ten years experience from a tertiary care center in a LMIC1
Challenges in improving global outcomes for hemophagocytic lymphohistiocytosis1
The pre-surgical factors that determine the decision to proceed to resection in children diagnosed with high-risk neuroblastoma in a resource limited setting1
KMT2A-rearranged diffuse large B-cell lymphoma in a child: a case report and molecular characterization1
Clinical outcomes and prognostic factors in children with B-cell lymphoblastic lymphoma (LBL) treated according to on modified BFM-90 protocol: Experience from a Tertiary cancer care center in India1
Non-inferiority of fragmented care for high-risk pediatric neuroblastoma patients: a single institution analysis1
Successful haploidentical bone marrow transplantation in Griscelli syndrome type 2 with non-busulfan-based regimen and post-transplantation cyclophosphamide: a case report and review of the literature1
Rare TCF3 variants associated with pediatric B cell acute lymphoblastic leukemia1
Fluoxetine-Induced Acquired Platelet Aggregation Defect: a Rare Cause of Oral Bleeding1
0.04451584815979